Protection against H9N2 Influenza A virus induced by recombinant NP-HA2 fusion protein

Protection against H9N2 Influenza A virus induced by recombinant NP-HA2 fusion protein


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: مریم زین العابدینی , مسعود مقدس زاده

عنوان کنگره / همایش: 31th European Congress of clinical Microbiology and Infectious Diseases , Austria , وین , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله مریم زین العابدینی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده پیراپزشکی
کد مقاله 77470
عنوان فارسی مقاله Protection against H9N2 Influenza A virus induced by recombinant NP-HA2 fusion protein
عنوان لاتین مقاله Protection against H9N2 Influenza A virus induced by recombinant NP-HA2 fusion protein
نوع ارائه سخنرانی
عنوان کنگره / همایش 31th European Congress of clinical Microbiology and Infectious Diseases
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Austria
شهر محل برگزاری کنگره/ همایش وین
سال انتشار/ ارائه شمسی 1399
سال انتشار/ارائه میلادی 2021
تاریخ شمسی شروع و خاتمه کنگره/همایش 1400/04/18 الی 1400/04/21
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Department of Basic Sciences, Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
مریم زین العابدینیاول
مسعود مقدس زادهدوم

اطلاعات تفضیلی
hide/show

عنوان متن
خلاصه مقالهBackground Influenza is as an extremely contagious respiratory tract disease. Influenza A virus is a member of the Orthomyxoviridae family that has segmented genome and great antigenic diversity. Influenza viruses possess multiple conserved epitopes that are designed for universal vaccines. These epitopes are the nucleoprotein (NP) and HA2. Methods In this survey, we have constructed new plasmids to express above-mentioned epitopes as a single recombinant product. To this aim, two peptide genes of N-terminal NP and HA2 were linked together with a (Gly4Ser) 4 peptide linker, synthesized, and cloned into pET26b vector. Then, the construct was transferred into E. coli BL21 (DE3) cells and induced using isopropyl β-D-1 thiogalactoside (IPTG). Immunization of mice with above peptides significantly induced humoral immune responses. Three weeks after the last booster, mice were inoculated intranasally with 1×106 EID50 of H9N2 virus. Results The recombinant NP-HA2 fusion protein gene was cloned into pET26b vector. The results of sequencing displayed that gene was properly cloned in vector. Also, SDS-PAGE showed a strong single band. Moreover, Western blot analysis indicated a single band in correct position. Real-time RT-PCR studies exhibited reduction of virus in BALB/c mice lung tissues. Our study revealed that this protein could protect mice against H9N2 virus. Conclusions The recombinant NP-HA2 fusion protein characterizes a potential candidate for influenza vaccine studies in animal model. According to the findings, the NP-HA2 fusion protein induced humoral immunity responses. The findings of this study suggest that the recombinant fusion peptide which is economical to yield can be used for induction specific antibodies responses. The results of the current study showed that above protein can protect mice by decreasing virus shedding.
کلمات کلیدیNP-HA2

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Final Programme of ECCMID 2021.pdf1400/09/0615031029دانلود
Acceptance.jpg1400/09/06189397دانلود
Protection against H9N2 Influenza A virus induced by recombinant NP-HA2 fusion protein (1).pdf1400/09/08130815دانلود